China’s 3H Health Investment has led a RMB450 million ($67 million) Series B round for local genetics-based drug discovery and therapeutics developer EdiGene.
Sequoia Capital China, Alwin Capital, and Kunlun Capital came in as new investors, while IDG Capital, Lilly Asia Ventures, Huagai Capital and Green Pine Capital Partners re-upped. It builds on a $10 million...
China Ping An Insurance Overseas Holdings has aspirations to manage assets for third-party investors. Spinning out part of the global private equity portfolio may help it get there
Buoyed by strong macro fundamentals and robust returns, Japan’s buyout managers continue to attract capital while most other strategies across Asia struggle. Will this popularity be sustained?
Zhenkunhang, a China-based distribution platform for industrial products, has raised $315 million Series E funding led by YF Capital - previously Yunfeng Capital - a private equity firm co-founded by Alibaba’s Jack Ma.
Japanese logistics technology start-up Openlogi has raised JPY1.7 billion ($16.7 million) in an ongoing Series C round featuring Sumitomo Corporation.